Mir-494 was introduced as an oncogenic microRNA to promote tumorigenesis in hepatocellular carcinoma [74], breast cancer by activating myeloid-derived suppressor cells (MDSCs) [75], and non-small-cell lung cancer (NSCLC) cells by inducing Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance [56]. This evidence concerns the gene TNFSF10 and non-small cell lung carcinoma.